CAREANDSELFLOVE

At 11:47 p.m., the clinic still exists.

Its website loads. The doctors are smiling. The Instagram page is full of new-baby photographs. Google Maps says the building will open at eight tomorrow morning.

But your coordinator’s email bounces back.

The patient portal no longer accepts your password. The phone rings without being answered. A woman in an online fertility group says the clinic has stopped paying employees. Someone else claims the laboratory has been sold. Then a short, strangely calm email appears:

Due to an internal restructuring, treatment services have been temporarily suspended.

Nothing in the message mentions your embryos.

Until that moment, you may have imagined those embryos as possibility: a second child, a final transfer, another chance after your body and bank account have recovered. Now they become something else—a set of cryopreserved specimens stored inside a building in another country, controlled by people you cannot reach.

I think this is one of the most frightening gaps in cross-border fertility care. Clinics are usually excellent at explaining how a journey begins. They show patients the consultation, stimulation, retrieval, fertilization and transfer.

Very few explain what happens if the clinic itself does not survive the journey.

When I examine an embryo-storage arrangement, I do not begin with the success rate. I begin with a less glamorous question:

If this organization disappeared tomorrow, what would still protect the embryos?

Not the brand.

Not the coordinator who “always replies within ten minutes.”

Not the glossy accreditation badge.

I want to know what protects the temperature, identity, legal authority and records. I call this the four-chain test:

Cold → identity → authority → information

If all four chains remain intact, embryos can often stay protected even while a clinic closes, changes ownership or stops providing treatment.

If one chain breaks, the embryos may become damaged, misidentified, legally inaccessible or practically impossible to transfer—even when they are still physically frozen.

This article is not designed to frighten anyone out of IVF abroad. Cross-border treatment can be excellent, ethical and financially life-changing. I wrote this because I do not believe hope should depend on a company continuing to answer its email.

What happens to frozen embryos if an IVF clinic closes?

The short answer is:

Closing an IVF clinic does not automatically mean that stored embryos are thawed, discarded or lost.

During a planned closure, embryos will usually need to remain in appropriate cryostorage until they can be transferred to another authorized facility or placed under a new responsible operator. A regulator, licence holder, laboratory director, administrator or receiving clinic may become involved.

However, there is no single international closure procedure.

What happens next depends on:

• why the clinic is closing;
• whether closure is temporary or permanent;
• whether the storage facility is closing too;
• which entity holds the laboratory licence;
• whether the clinic is insolvent, sold or under investigation;
• the country’s fertility and tissue-storage laws;
• the patient’s current consent;
• who has authority over the embryos;
• whether storage fees are current;
• whether another clinic can legally accept them;
• whether the records are complete enough for transfer and future use.

Professional standards recognize that fertility laboratories need more than a fire alarm. IVF programs should maintain written emergency plans covering patients, cryopreserved specimens, essential records, equipment and the continuation or cessation of care.

The latest ESHRE laboratory recommendations similarly address traceability, cryopreservation, quality management, emergency communication and continuity procedures.

That is reassuring at the level of professional expectations.

It is not proof that every clinic has a workable plan.

First, find out what “closed” actually means

I would never make a transfer decision based only on a phrase such as clinic closure. That phrase can describe several completely different situations.

A fertility centre can stop performing retrievals while its storage laboratory continues operating normally. A treatment company can become insolvent while a separately licensed storage provider remains stable. A regulator can suspend one activity without ordering the facility to move cryopreserved material.

Conversely, a clinic may continue posting on social media while its laboratory staffing, insurance or licence is already under pressure.

Before asking, “Where should I move the embryos?” I would ask, “What exactly has stopped?”

I would resist two opposite reactions.

The first is denial: “The clinic said everything is fine, so I will wait.”

The second is panic: “I need to move the embryos tomorrow.”

Both can be risky.

If a validated tank is stable and monitored, an improvised international shipment may introduce avoidable handling and administrative problems. If staffing, nitrogen supply or authorization is genuinely at risk, waiting for the coordinator to return may waste crucial time.

I want evidence before movement.

The clinic may disappear while the embryos remain safely frozen

This feels counterintuitive because patients naturally connect the clinic with the embryos.

Yet the treatment clinic, storage laboratory, contracting company and public-facing brand may not be the same entity.

A clinic can close its consultation rooms while embryos remain inside a functioning cryostorage facility. The treatment brand can be sold while the laboratory continues under its original licence. The embryos may already be stored off-site by another provider whose name appears only in the contract’s small print.

That is why I would locate four separate entities:

1. The brand patients see online.
2. The company named in the contract and invoices.
3. The licensed medical or laboratory operator.
4. The facility physically storing the embryos.

Sometimes all four names are identical.

Sometimes they are not even located at the same address.

I would write each verified legal name on one page. If the clinic refuses to identify the physical storage site or current licence holder, I would treat that as a serious warning.

A famous doctor’s name does not answer the question.

Neither does a customer-service agent saying, “They are in our laboratory.”

I want the laboratory’s full name, address, authorization number, responsible person and regulator.

Chain one: cold

The first chain is physical survival.

Embryos are not stored in an ordinary electric freezer. Vitrified embryos are held at extremely low temperatures in liquid-nitrogen storage systems. Their protection depends on more than whether the building has electricity.

A responsible cryostorage system needs:

• validated storage tanks;
• reliable liquid-nitrogen supply;
• monitoring of nitrogen levels or temperature;
• alarms that reach staff outside working hours;
• clear escalation if the first person does not respond;
• documented manual checks;
• backup tank capacity;
• trained staff;
• ventilation and staff-safety procedures;
• accurate tank-location records;
• an emergency response plan.

ASRM recommends electronically monitored storage tanks, remote alarms, regular review of liquid-nitrogen levels and sufficient backup capacity to move specimens from a tank showing abnormal nitrogen loss. Its guidance also acknowledges that even a well-maintained tank can experience a rare catastrophic failure.

I mention this not to make patients inspect laboratory machinery. That is not our job.

I mention it because “the embryos remain frozen” is not a complete answer.

I would ask:

• Who is currently checking the tanks?
• Who receives alarms overnight?
• Is nitrogen delivery continuing during insolvency or closure?
• Is there space in a validated backup tank?
• Has staffing changed since the closure announcement?
• Has the regulator inspected or reviewed the storage arrangements?
• Is the site expected to remain operational until all transfers are complete?

The strongest answer is specific.

“We have 24-hour monitoring, two named embryologists on the emergency rota, a current nitrogen-supply contract and validated backup capacity” means something.

“Your embryos are perfectly safe, please do not worry” does not tell me how safety is being maintained.

Chain two: identity

An embryo can remain perfectly cold and still become unusable if its identity cannot be reliably connected to the correct patient, consent and laboratory history.

That is why the second chain is traceability.

A cryostorage inventory should connect the patient to:

• the number of embryos;
• embryo identifiers;
• dates of fertilization and cryopreservation;
• developmental stage;
• grading information;
• the storage device;
• the tank and location;
• the vitrification method;
• relevant donor information;
• genetic-testing results, where applicable;
• every movement into or out of storage.

ESHRE’s 2026 recommendations emphasize permanent, secure and accessible traceability records, unique identification and documented systems for non-conformities, incidents and corrective action.

When a clinic closes, I would not settle for a portal screenshot stating:

Embryos in storage: 4

I would request a dated inventory produced or confirmed by the laboratory.

If the embryos underwent preimplantation genetic testing, I would also request the record linking each embryo identifier to the corresponding PGT result. A genetic report without reliable embryo mapping is not a complete portable record.

My preferred question would be:

“Please provide a dated and signed inventory of all embryos connected to my case, including their identifiers, developmental stage, cryopreservation date and exact physical storage facility.”

I would save that document outside the patient portal.

A portal is useful until the day the portal becomes part of the closure.

Chain three: authority

This is where many reassuring explanations become dangerously vague.

Patients often say, “They are my embryos.” Emotionally, I understand exactly what that means.

Legally, the question may be more complicated.

Countries use different approaches to embryos, consent and dispositional control. A storage contract may call one person the client, while the embryos were created using the gametes of two people whose authorization is required for particular decisions.

Different forms may govern different actions:

• continued storage;
• export;
• import;
• transfer to another storage facility;
• use in treatment;
• donation;
• research;
• disposal;
• use after death;
• decisions following separation or divorce.

I therefore avoid relying on one broad question—“Who owns the embryos?”—as though it must produce one universal answer.

I ask:

Who has authority to approve this specific action, under which consent form and which country’s law?

The person paying the storage invoice may not have unilateral authority to move or use jointly created embryos.

A clinic may require both signatures for transfer even if one person has paid every bill. Donor eggs or sperm may create additional documentation requirements. Death, incapacity, separation or a legal-name change can complicate an already difficult transfer.

ASRM recommends that programs obtain written instructions concerning the future disposition of cryopreserved embryos and maintain clear policies for embryos whose controlling individuals cannot be contacted. Under defined policies, applicable law and reasonable contact procedures, embryos may eventually be treated as unclaimed.

That does not mean a clinic can discard embryos because one email was missed.

It does mean I would never allow an old address, expired consent or unreachable former partner to remain an invisible weakness in the plan.

Chain four: information

This may be the chain patients underestimate most.

Embryos can be physically safe, correctly labelled and legally controlled—yet still become difficult to move because the receiving clinic does not have enough information to accept them.

Imagine receiving this answer:

The embryos are safe, but we cannot release the full records because the patient database belongs to the former operating company.

Or:

The PGT laboratory report exists, but the file connecting embryo numbers to test results cannot be located.

Or:

The receiving clinic will not accept the embryos because infectious-disease screening, donor documentation or consent does not meet its requirements.

The embryos have not been lost.

But access to future treatment has become uncertain.

This is why I treat records as part of clinical safety rather than administrative decoration.

ASRM’s emergency-planning guidance includes the protection of important clinical and laboratory records alongside specimens and equipment. Comprehensive laboratory guidance also recommends written protocols and detailed documentation for the receipt, movement, storage and shipment of cryopreserved reproductive material.

I want my file to be understandable to someone who has never spoken with the original coordinator.

Build an embryo continuity passport

I use the word passport deliberately.

A passport does not own the traveller. It creates verified continuity between identity, authority and movement.

Your Embryo Continuity Passport should do something similar. It should contain enough organized information for an authorized receiving clinic, regulator or lawyer to understand the case without reconstructing it from scattered emails.

I would keep it in a secure, encrypted location and update it after every material change.

I would add a one-page cover sheet containing:

• patient names and any previous legal names;
• dates of birth;
• clinic case number;
• date the embryos were created;
• current number of embryos;
• physical storage location;
• licence holder;
• regulator;
• laboratory contact;
• next consent date;
• paid-through date;
• emergency contact details;
• names of everyone whose authorization may be required.

The cover sheet is not evidence by itself.

It is a map to the evidence.

Consent and payment are not the same thing

If I could correct one misunderstanding about embryo storage, it would be this:

Paying for storage does not necessarily renew legal consent, and valid consent does not necessarily mean the storage bill has been paid.

I track these as two separate systems.

The UK changed its legal storage framework in 2022, requiring clinics to contact affected patients and obtain updated consent for continued storage. The HFEA’s 2024/25 report still identified storage continuing after consent had expired as an example of major non-compliance.

That example comes from one regulatory system, not a universal rule. But the underlying lesson travels well.

I would place four recurring reminders in my calendar:

1. Check contact details.
2. Confirm the paid-through date.
3. Confirm the consent-renewal date.
4. Request a new inventory statement.

I would repeat the check at least every six months while embryos remained abroad.

That is not obsessive monitoring.

It is routine maintenance for reproductive material that cannot correct an outdated email address.

The contract cannot protect what it does not explain

Many storage agreements contain a sentence that sounds reassuring:

If the clinic ceases operating, stored material may be transferred to another authorized facility.

I would not stop reading there.

I would ask:

• Who selects the receiving facility?
• Can I refuse the clinic’s proposed destination?
• Can I choose a clinic in another country?
• Who pays for release, permits, transport and new storage?
• Will prepaid storage be refunded?
• What happens if the receiving clinic rejects the documentation?
• Can the clinic transfer embryos without obtaining new instructions?
• Which company assumes responsibility after a sale?
• Which country’s law governs the agreement?
• Where must a dispute be brought?
• What happens if two people with authority disagree?
• What happens after death or loss of capacity?
• How long will records remain accessible after closure?

I would also save the exact version of the contract I signed.

Web pages change. Portals update their terms. A new company may publish a new fee schedule. I want the document that governed the relationship when the embryos entered storage.

Informed consent is not simply a signature collected before treatment. It is a process in which patients understand the relevant risks, alternatives and consequences well enough to make a voluntary decision aligned with their values.

For me, a meaningful storage consent should include what happens when storage cannot continue at the original clinic.

The clinic’s disappearance should not be the first time the patient sees the exit plan.

How are embryos transferred to another clinic?

I would not describe embryo transfer between clinics as shipping a package.

I would describe it as a controlled transfer of custody between authorized laboratories.

A safe route normally involves several stages:

Receiving clinic reviews the case → receiving clinic formally agrees to accept the embryos → consents and permits are completed → the sending laboratory reconciles the inventory → a suitable cryogenic shipper is prepared → custody is documented → the receiving laboratory confirms arrival → a new inventory is issued.

The receiving clinic should come before the courier.

That order matters.

A transport company can move a validated container. It cannot decide whether a clinic may lawfully accept or use the embryos.

ASRM guidance states that cryopreserved reproductive specimens should be transported in dry liquid-nitrogen shippers capable of maintaining temperatures below −150°C. It also notes that many ordinary commercial carriers do not insure reproductive specimens and recommends written laboratory procedures for shipping and receipt.

Before authorizing movement, I would want written answers to four questions:

1. Has the receiving clinic reviewed the complete file?
2. Has it formally agreed to accept these specific embryos?
3. Are all legal and laboratory requirements complete?
4. Who holds responsibility at every stage of the journey?

I would also ask for confirmation after arrival.

Not simply, “The delivery was completed.”

I want the receiving laboratory to confirm that the shipper arrived, the documentation was reviewed and the embryos were entered into its own storage inventory.

Can another clinic refuse to accept the embryos?

Yes.

That refusal does not automatically mean the embryos are damaged or illegal.

A clinic may decline because:

• documentation is incomplete;
• identifiers do not satisfy its traceability requirements;
• donor records are insufficient;
• infectious-disease screening is missing or incompatible;
• storage devices or methods are unfamiliar;
• import rules are not satisfied;
• the intended treatment is restricted locally;
• consent does not authorize the proposed movement;
• PGT records cannot be reliably matched;
• the clinic does not accept material from certain jurisdictions;
• the clinic’s own policies are stricter than the legal minimum.

Cross-border reproductive care operates between systems with different clinical standards, consent rules, donor frameworks and legal restrictions. ASRM recognizes both the benefits and the possible harms of this fragmented environment for patients, offspring and other participants.

This is why I would never book collection first and ask the receiving clinic later.

If a permanent international destination cannot be chosen quickly, I would ask whether a regulated storage-only facility in the same country could accept the embryos temporarily. That may reduce the immediate risk created by a failing business while preserving time for a careful long-term decision.

The option will not exist everywhere, but it is worth asking.

What if the clinic is bankrupt?

Bankruptcy creates a particularly confusing overlap between health care and business law.

The company that received your payment may no longer control the laboratory. The embryologists may work for another entity. The cryotanks may be owned or leased. The patient-record system may be provided by an external company. The storage facility may operate under a separate licence.

I would refuse to let one familiar logo hide those distinctions.

My first step would be to identify:

• the legal company named in my contract;
• the entity receiving storage payments;
• the current licence holder;
• the physical storage operator;
• the insolvency administrator;
• the regulator or competent health authority;
• the party controlling the clinical and laboratory records.

I would not make a new payment merely because an urgent email contained the old clinic logo.

I would verify which entity is legally entitled to receive the money and exactly what the payment purchases.

I would also be careful with phrases such as ownership of embryos. An insolvency process does not by itself answer questions of consent, use, disposition or reproductive authority. These questions may require specialist advice under the fertility and contract laws of the storage country.

If a dispute develops, I would seek an independent lawyer rather than one recommended solely by the clinic, buyer or administrator.

The person arranging the transition may be helpful.

That does not make that person my legal advocate.

What if the clinic has been sold but continues trading?

A sale can be almost invisible to patients.

The doctors stay. The website stays. The same coordinator writes from the same desk.

But the contracting entity, price structure, insurance, licence or storage provider may have changed.

I would ask the new operator to confirm in writing:

• that it has accepted responsibility for the stored embryos;
• the date responsibility transferred;
• the current physical storage location;
• whether embryo identifiers and records were reconciled;
• whether existing consent remains valid;
• whether prepaid storage will be honored;
• whether the former transfer and closure terms still apply;
• whether fees or release conditions have changed;
• which regulator approved or recorded the change.

I would not assume that “nothing changes for patients” means literally nothing changes.

Sometimes it means only that the company prefers a quiet transition.

What if the clinic closes because its licence is suspended?

A suspended licence does not always mean that every clinic activity stops at once.

An authority may prohibit new treatment while allowing storage to continue under conditions. It may require supervision, appoint another responsible operator or direct the movement of stored material.

The exact scope matters.

I would read the regulator’s notice rather than relying on media headlines or patient-group summaries. Then I would ask:

1. Which activities are suspended?
2. Is cryostorage still legally authorized at the facility?
3. Who is currently responsible for the laboratory?
4. Has an inventory been ordered?
5. Will the regulator supervise transfer?
6. How will individual patients be contacted?
7. Is there a deadline for choosing another clinic?
8. Who pays unavoidable transfer expenses?

The clinic’s social-media page is not the authoritative source for licence status.

Neither is a reassuring voice note from a coordinator.

What if there has been a cryostorage incident?

A clinic closure is not the same as a tank failure.

But financial or regulatory pressure can uncover weaknesses that previously remained hidden.

If I received notice of a tank, alarm, labelling, witnessing or handling incident, I would request an individualized written disclosure.

I would ask:

• Were my embryos in the affected tank, canister, batch or workflow?
• How was that determined?
• Was a complete inventory performed?
• Who performed and witnessed it?
• Were embryo identifiers reconciled against laboratory records?
• Was temperature or nitrogen-level data reviewed?
• Was the regulator notified?
• Was a root-cause analysis started?
• What immediate corrective action was taken?
• When will I receive the final report?

ASRM states that clinically significant errors involving gametes or embryos should be disclosed to affected patients. Clinics should also investigate system failures and implement corrective action.

I would pay close attention to the difference between these statements:

• “We have received no report of damage.”
• “Your embryos were not stored in the affected tank.”
• “Your embryos were individually reconciled.”
• “Their condition has been clinically assessed.”

Those sentences are not equivalent.

If an incident may have harmed or misdirected embryos, I would preserve all records and obtain independent medical and legal advice before accepting compensation, replacement treatment or a settlement agreement.

My 48-hour plan after receiving a closure email

The first 48 hours should create evidence, not movement for the sake of movement.

Hours 0–2: preserve access

I would download:

• all consent forms;
• the storage contract;
• invoices and payment confirmations;
• embryo inventory statements;
• the full embryology report;
• PGT reports;
• donor documents legally available to me;
• correspondence about storage or disposition;
• the closure announcement;
• licence and regulator details shown in the portal.

I would also record the clinic’s physical address, legal company name, official phone numbers and names of key staff.

I would not keep the only copy inside the clinic’s system.

Hours 2–6: verify independently

I would check the official register or contact the competent authority through contact details obtained independently of the clinic.

I would ask whether:

• the clinic’s licence remains active;
• storage is still authorized;
• the regulator knows about the closure;
• another operator has been appointed;
• patients should take immediate action;
• an official notice or patient helpline exists.

Hours 6–24: test the four chains

I would request written confirmation of:

• cold: current storage and monitoring;
• identity: my dated embryo inventory;
• authority: who can authorize continued storage or transfer;
• information: access to the complete portable file.

I would confirm the next consent date and paid-through date separately.

Hours 24–48: create options

I would contact one or two possible receiving clinics and ask them to review the documentation before discussing courier dates.

I would obtain a full estimate covering:

• sending-clinic release;
• laboratory administration;
• permits;
• translation;
• courier;
• receiving-clinic review;
• acceptance;
• new storage;
• legal advice if necessary.

A low transport quote is not the total cost of transfer.

An email I would send to the clinic

Subject: Urgent written confirmation of embryo storage and continuity arrangements

Dear [Clinic or Laboratory Director],

Following the notice concerning the clinic’s [closure, suspension, restructuring or change of ownership], please provide written confirmation of the following:

1. The exact facility where my embryos are physically stored.
2. The current licence holder and responsible laboratory professional.
3. Whether cryostorage remains fully operational and continuously monitored.
4. A dated inventory of all embryos connected to my case, including their identifiers, stages and cryopreservation dates.
5. The expiration or renewal dates of all current storage consents.
6. My storage-fee status and paid-through date.
7. The entity currently responsible for my clinical, embryology, genetic-testing and consent records.
8. The approved continuity or closure plan for stored embryos.
9. Whether I may select my own receiving clinic.
10. All requirements, fees and deadlines for domestic or international transfer.

Please also identify the competent regulator or authority overseeing the current arrangements.

I would appreciate a written response from the laboratory or legally responsible operator, rather than a general marketing or customer-service statement.

Kind regards,
[Name]
[Date of birth]
[Clinic reference number]

I would send this through more than one official channel if necessary and save proof of delivery.

A seven-day practice corner: the disappearing clinic drill

I do not believe preparedness has to feel like catastrophe planning.

This exercise takes one week and can be completed while the clinic is functioning normally. Each day should produce one piece of evidence.

The purpose is not to convince myself that the clinic will fail.

It is to make sure that, if it does, fear will not be my only source of momentum.

The emotional risk: paying to make the fear stop

When embryos are stored abroad, distance amplifies helplessness.

You cannot drive to the clinic and ask to see the tank. You may not speak the local language. The clinic may be several time zones away. A coordinator offers one solution:

Pay today, and we will take care of everything.

Payment creates movement.

Movement creates temporary relief.

I understand why that can feel irresistible.

Before paying, I would still ask:

• Who receives the money?
• Is that entity authorized to provide the promised service?
• Has the receiving laboratory already accepted the embryos?
• Is the payment refundable if transfer cannot legally proceed?
• Does the fee include permits and laboratory charges?
• Who bears the risk during transport?
• What happens if records are incomplete?
• Does the new contract change my future choices?
• Is the deadline regulatory, operational or purely commercial?

Some deadlines are real.

A closure process may have a final transfer date. A regulator may impose conditions. A storage facility may cease operations on a documented schedule.

“Only three transfer spaces remain” is not the same type of deadline.

I would ask for the reason in writing.

Questions I would ask before storing embryos abroad

I would rather have this conversation before retrieval than during a closure.

My questions would include:

1. Where will the embryos be physically stored?
2. Is the storage facility separate from the treatment clinic?
3. Which authority regulates it?
4. Who is professionally responsible for the laboratory?
5. How are tanks monitored outside working hours?
6. What backup capacity exists?
7. What is the plan for fire, flood, staffing failure, insolvency, cyberattack or licence suspension?
8. Has a backup facility agreed to accept material in an emergency?
9. Can I choose a receiving clinic after closure?
10. Who pays for a mandatory transfer?
11. Which consents are required for continued storage, movement and future use?
12. What happens after separation, death or incapacity?
13. What happens if the clinic cannot contact me?
14. How long are records retained?
15. Can I receive my complete file now?
16. Which information accompanies an international transfer?
17. What insurance covers storage and transport incidents?
18. Which legal entity holds my contract?
19. Which law governs disputes?
20. What happens to prepaid storage if the company is sold or closes?

A clinic does not have to promise immortality.

I want it to demonstrate continuity.

Is Europe creating stronger protection?

The European Union adopted Regulation (EU) 2024/1938 concerning substances of human origin, including reproductive cells and tissues such as gametes and embryos. The framework strengthens areas including traceability, competent oversight, vigilance, crisis preparedness and resilience.

Most of the new framework applies from August 2027. Until then, existing EU tissue-and-cell rules and the national laws implementing them continue to matter.

Even after the new framework applies, it will not make every fertility law identical.

Countries may continue to differ on:

• embryo-storage duration;
• consent withdrawal;
• donor information;
• export and import;
• posthumous use;
• research;
• embryo donation;
• parentage;
• access to treatment;
• permitted embryo testing.

I would therefore never accept the sentence “EU regulations cover it” as the complete legal answer.

I want to know which authority and which rule govern the specific decision today.

Outside the European Union, oversight may involve national fertility regulators, state or regional law, professional accreditation, tissue legislation, general health-facility licensing or several systems at once.

An international badge is not necessarily a storage licence.

I would verify both.

The answer I trust is not “nothing will happen”

A clinic that tells me nothing can go wrong does not make me feel safer.

A clinic that tells me exactly what happens when something goes wrong does.

The answer I trust sounds like this:

If treatment operations cease, the laboratory remains staffed under licence. Stored material continues to be monitored. Patients receive a dated inventory and copies of their records. Our regulator is notified. A pre-approved receiving facility can accept storage, although patients may request another eligible clinic. No embryo moves until consent, acceptance and custody documentation are complete.

That answer contains a system.

“We have never had a problem” contains only history.

I want an exit plan before I need an escape

I do not think fertility patients should have to approach every clinic as a possible crime scene.

I also do not think we should confuse trust with the absence of questions.

When embryos are stored abroad, I want more than confidence in the doctor who created them. I want confidence that the entire route remains usable if that doctor retires, the clinic is sold, the company becomes insolvent or the regulator stops treatment.

I want the four chains intact:

Cold → the embryos remain physically protected.

Identity → the laboratory can prove exactly which embryos belong to the case.

Authority → it is clear who may decide what happens next.

Information → another authorized clinic can understand and accept the file.

A tank can remain cold for years.

A contract can become inaccessible overnight.

A coordinator can leave on Friday.

A clinic can keep its beautiful website long after its internal structure has started to fail.

That is why I would create the continuity passport now. I would download the records now. I would learn the licence holder’s name now. I would track consent and payment separately. I would test whether another clinic could accept the embryos. I would ask the clinic to describe its own disappearance while everyone is still comfortably assuming it will never happen.

This preparation does not make hope smaller.

It prevents hope from being held hostage by one company, one password or one unanswered telephone.

My final question would not be:

“Do you promise my embryos will always be safe?”

No responsible clinic can make an absolute promise.

I would ask:

“If you cannot protect them tomorrow, show me exactly who will.”

Related posts You’ll love

• Why fertility tourism is becoming the wild west of reproduction
• Pregnancy loss and infertility boundaries: What to say when people ask (compassionate scripts that protect Your heart)
• How to respond when Women are blamed for falling birth rates: 15 calm, evidence-based scripts
• Why Women are blamed for falling birth rates—and what actually causes demographic decline
• The 7-day age anxiety reset: A science-informed plan to stop treating every new line like an emergency, FREE PDF
• Why Women are expected to look 35 forever—and what this pressure is really doing to us

Editorial medical and legal note

This article provides general education and a practical decision-support framework. It does not provide individualized medical or legal advice. Laws governing embryo storage, consent, transfer, import, export, donation, disposition and posthumous use vary between jurisdictions and can change. Patients should consult an appropriately licensed reproductive-medicine specialist and an independent lawyer familiar with every relevant country before making decisions about stored embryos.

FAQ

Sources and inspirations

• American Society for Reproductive Medicine Ethics Committee. (2021). Disposition of unclaimed embryos: An Ethics Committee opinion. Fertility and Sterility.
• American Society for Reproductive Medicine Ethics Committee. (2022). Cross-border reproductive care: An Ethics Committee opinion. Fertility and Sterility.
• American Society for Reproductive Medicine Ethics Committee. (2023). Informed consent in assisted reproduction: An Ethics Committee opinion. Fertility and Sterility.
• American Society for Reproductive Medicine Ethics Committee. (2024). Disclosure of medical errors and untoward events involving gametes and embryos: An Ethics Committee opinion. Fertility and Sterility.
• American Society for Reproductive Medicine Practice Committee, & Society for Reproductive Biologists and Technologists Practice Committee. (2022). Comprehensive guidance for human embryology, andrology, and endocrinology laboratories: Management and operations: A committee opinion. Fertility and Sterility.
• Arroyo, G., Barrie, A., Coticchio, G., Ebner, T., Kirkman-Brown, J., Le Clef, N., Lundin, K., Magli, C., Quesada Martinez, M., de los Santos Molina, M. J., Tilleman, K., & Sfontouris, I. (2026). ESHRE recommendations on good practice in the IVF laboratory. Human Reproduction.
• European Parliament & Council of the European Union. (2024). Regulation (EU) 2024/1938 on standards of quality and safety for substances of human origin intended for human application. Official Journal of the European Union.
• Human Fertilisation and Embryology Authority. (2022, July 1). New law comes into force giving greater flexibility for fertility patients.
• Human Fertilisation and Embryology Authority. (2025). The fertility sector 2024/25.
• Practice Committees of the American Society for Reproductive Medicine, Society for Assisted Reproductive Technology, & Society of Reproductive Biologists and Technologists. (2020). Cryostorage of reproductive tissues in the in vitro fertilization laboratory: A committee opinion. Fertility and Sterility.
• Practice Committees of the American Society for Reproductive Medicine, Society for Assisted Reproductive Technology, & Society of Reproductive Biologists and Technologists. (2021). Development of an emergency plan for in vitro fertilization programs: A committee opinion. Fertility and Sterility.